SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-022999
Filing Date
2022-06-10
Accepted
2022-06-10 16:30:30
Documents
13
Period of Report
2022-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K avro-8k_20220608.htm   iXBRL 8-K 57801
2 EX-10.1 avro-ex101_6.htm EX-10.1 15270
  Complete submission text file 0001564590-22-022999.txt   213800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20220608.xsd EX-101.SCH 5689
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20220608_lab.xml EX-101.LAB 20939
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20220608_pre.xml EX-101.PRE 12486
7 EXTRACTED XBRL INSTANCE DOCUMENT avro-8k_20220608_htm.xml XML 3811
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 221009316
SIC: 2836 Biological Products, (No Diagnostic Substances)